Terms: = Breast cancer AND ETV6, TEL/ABL, 2120, ENSG00000139083, P41212, TEL AND Treatment
61 results:
1. Genetic and clinical landscape of ER + /PR- breast cancer in China.
Dai D; Wu H; Zhuang H; Chen R; Long C; Chen B
BMC Cancer; 2023 Dec; 23(1):1189. PubMed ID: 38049758
[TBL] [Abstract] [Full Text] [Related]
2. A case report and literature review on a rare subtype of triple-negative breast cancer in children.
Shi L; Zhang Y; Wu J; Li J; Zhu J; Xu Y; Li N; Li Q; Zhang W
BMC Pediatr; 2023 Sep; 23(1):494. PubMed ID: 37773118
[TBL] [Abstract] [Full Text] [Related]
3. Secretory carcinoma of salivary glands with NTRK3 break-apart molecular rearrangement: Potential misdiagnosis with mucoepidermoid carcinoma.
Nocini R; Sanna G; Trotolo A; Fior A; Brunelli M; Manfrin E; Favero V
J Stomatol Oral Maxillofac Surg; 2023 Dec; 124(6S):101635. PubMed ID: 37709146
[TBL] [Abstract] [Full Text] [Related]
4. Precision oncology using organoids of a secretory carcinoma of the salivary gland treated with TRK-inhibitors.
Lassche G; van Engen-van Grunsven ACH; van Hooij O; Aalders TW; Am Weijers J; Cocco E; Drilon A; Hoischen A; Neveling K; Schalken JA; Verhaegh GW; van Herpen CML
Oral Oncol; 2023 Feb; 137():106297. PubMed ID: 36610231
[TBL] [Abstract] [Full Text] [Related]
5. Metastatic triple negative breast cancer with NTRK gene fusion on tissue but not on ctDNA molecular profile.
Singh N; Singh R; Decker B; Robins D; Vidal G
BMJ Case Rep; 2022 Oct; 15(10):. PubMed ID: 36223973
[TBL] [Abstract] [Full Text] [Related]
6. The antiviral drug telaprevir induces cell death by reducing FOXA1 expression in estrogen receptor α (ERα)-positive breast cancer cells.
Bartoloni S; Leone S; Pescatori S; Cipolletti M; Acconcia F
Mol Oncol; 2022 Oct; 16(19):3568-3584. PubMed ID: 36056637
[TBL] [Abstract] [Full Text] [Related]
7. Secretory Carcinoma of the breast Mimicking Invasive Ductal Carcinoma: A Case Report.
Kovalenko I; Roy P; Soni B; Sangha L; Toom S
Am J Case Rep; 2022 Aug; 23():e936665. PubMed ID: 35982591
[TBL] [Abstract] [Full Text] [Related]
8. The genomic profile of double primary secretory breast carcinoma in one patient provides evidence for the treatment of such carcinoma: A case report.
Lei T; Deng X; Peng Y; Chen T
Pathol Res Pract; 2022 Aug; 236():154006. PubMed ID: 35810566
[TBL] [Abstract] [Full Text] [Related]
9. TRK Inhibition with Entrectinib in Metastatic Salivary Secretory Carcinoma (SC): A Case Report.
Ernst MS; Lysack JT; Hyrcza MD; Chandarana SP; Hao D
Curr Oncol; 2022 May; 29(6):3933-3939. PubMed ID: 35735423
[TBL] [Abstract] [Full Text] [Related]
10. [breast cancer-RELATED LYMPHEDEMA: INCIDENCE AND RISK FACTORS, PREVENTIVE MEASURES AND treatmentS].
Kedar DJ; Yanko R; Barnea Y; Inbal A; Fliss E; Zaretski A
Harefuah; 2022 Feb; 161(2):115-120. PubMed ID: 35195974
[TBL] [Abstract] [Full Text] [Related]
11. Fusion-associated carcinomas of the breast: Diagnostic, prognostic, and therapeutic significance.
Loo SK; Yates ME; Yang S; Oesterreich S; Lee AV; Wang XS
Genes Chromosomes Cancer; 2022 May; 61(5):261-273. PubMed ID: 35106856
[TBL] [Abstract] [Full Text] [Related]
12. KIR-HLA Functional Repertoire Influences Trastuzumab Efficiency in Patients With HER2-Positive breast cancer.
Muraro E; De Zorzi M; Miolo G; Lombardi D; Scalone S; Spazzapan S; Massarut S; Perin T; Dolcetti R; Steffan A; De Re V
Front Immunol; 2021; 12():791958. PubMed ID: 35095867
[TBL] [Abstract] [Full Text] [Related]
13. An injectable superior depot of telratolimod inhibits post-surgical tumor recurrence and distant metastases.
Liu Y; Li C; Xia H; Bi J; Guan R; Du X; Zhang H; He Z; Wang Y; Liu H
Acta Biomater; 2022 Mar; 141():132-139. PubMed ID: 35032721
[TBL] [Abstract] [Full Text] [Related]
14. Secretory breast carcinoma in a female adult with liver metastsis: a case report and literature review.
Lian J; Wang LX; Guo JH; Bu P; Xi YF; Yun KM
Diagn Pathol; 2021 Oct; 16(1):89. PubMed ID: 34629079
[TBL] [Abstract] [Full Text] [Related]
15. Secretory Carcinoma in Children and Young Adults: A Case Series.
Simon CT; McHugh JB; Rabah R; Heider A
Pediatr Dev Pathol; 2022; 25(2):155-161. PubMed ID: 34606389
[TBL] [Abstract] [Full Text] [Related]
16. Patterns of care of breast cancer patients in Morocco - A study of variations in patient profile, tumour characteristics and standard of care over a decade.
Mrabti H; Sauvaget C; Benider A; Bendahhou K; Selmouni F; Muwonge R; Alaoui L; Lucas E; Chami Y; Villain P; Abousselham L; Carvalho AL; Bennani M; Errihani H; Sankaranarayanan R; Bekkali R; Basu P
Breast; 2021 Oct; 59():193-202. PubMed ID: 34280610
[TBL] [Abstract] [Full Text] [Related]
17. Simultaneous quantification of abemaciclib and its active metabolites in human and mouse plasma by UHPLC-MS/MS.
Martínez-Chávez A; Tibben MM; de Jong KAM; Rosing H; Schinkel AH; Beijnen JH
J Pharm Biomed Anal; 2021 Sep; 203():114225. PubMed ID: 34242947
[TBL] [Abstract] [Full Text] [Related]
18. Diagnostic challenges and successful organ-preserving therapy in a case of secretory carcinoma of minor salivary glands.
Bill R; Deschler DG; Pittet MJ; Pai SI; Sadow PM; Park JC
Cancer Rep (Hoboken); 2022 Mar; 5(3):e1491. PubMed ID: 34231337
[TBL] [Abstract] [Full Text] [Related]
19. Locally Recurrent Secretory Carcinoma of the breast with NTRK3 Gene Fusion.
Mortensen L; Ordulu Z; Dagogo-Jack I; Bossuyt V; Winters L; Taghian A; Smith BL; Ellisen LW; Kiedrowski LA; Lennerz JK; Bardia A; Spring LM
Oncologist; 2021 Oct; 26(10):818-824. PubMed ID: 34176200
[TBL] [Abstract] [Full Text] [Related]
20. Secretory carcinoma of the breast with multiple distant metastases in the brain and unfavorable prognosis: a case report and literature review.
Tang H; Zhong L; Jiang H; Zhang Y; Liang G; Chen G; Xie G
Diagn Pathol; 2021 Jun; 16(1):56. PubMed ID: 34162406
[TBL] [Abstract] [Full Text] [Related]
[Next]
